Oncimmune Holdings PLC PDMR Dealing (6470G)
March 18 2020 - 7:19AM
UK Regulatory
TIDMONC
RNS Number : 6470G
Oncimmune Holdings PLC
18 March 2020
Oncimmune Holdings plc
("Oncimmune" or the "Company")
PDMR Dealing
Oncimmune Holdings plc (AIM: ONC.L), a leader in the
development, manufacture and commercialisation of personalised
immunodiagnostics for the screening, detection and care of cancer,
has been notified that Geoffrey Hamilton-Fairley, PDMR and
Non-Executive Vice Chairman, has purchased 25,000 ordinary shares
of GBP0.01 each in the Company ("Ordinary Shares") for 41 pence per
share on 18 March 2020.
Following this transaction, Geoffrey has a total interest in the
Company of 3,238,070 Ordinary Shares, representing approximately
5.12 per cent of the Company's issued Ordinary Share capital.
This announcement, including the notification below, is made in
accordance with the requirements of Article 19 of the EU Market
Abuse Regulation.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Geoffrey Hamilton-Fairley
----------------------------------- --------------------------------------
2 Reason for the notification
---------------------------------------------------------------------------
a) Position/status Non-Executive Vice Chairman
----------------------------------- --------------------------------------
b) Initial Initial notification
notification
/Amendment
----------------------------------- --------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------
a) Name Oncimmune Holdings plc
----------------------------------- --------------------------------------
b) LEI 213800HCYIWT6YPI1I02
----------------------------------- --------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---------------------------------------------------------------------------
a) Description Ordinary Shares of GBP0.01 each
of the financial
instrument,
type of
instrument
Identification ISIN: GB00BYQ94H38
code
b) Nature of Purchase of shares
the transaction
----------------------------------- --------------------------------------
c) Price(s)
and volume(s)
------------------- --------------
Price Volume
------------------- --------------
GBP0.41 25,000
------------------------------------------------------------ --------------
d) Aggregated
information
- Aggregated Same as above
volume
- Price
e) Date of 18 March 2020
the transaction
----------------------------------- --------------------------------------
f) Place of London stock exchange, AIM
the transaction
----------------------------------- --------------------------------------
For further information:
Oncimmune Holdings plc
Andrew Stewart, General Counsel and Company Secretary
contact@oncimmune.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHKKFBDBBKDDND
(END) Dow Jones Newswires
March 18, 2020 08:19 ET (12:19 GMT)
Oncimmune (LSE:ONC)
Historical Stock Chart
From Apr 2024 to May 2024
Oncimmune (LSE:ONC)
Historical Stock Chart
From May 2023 to May 2024